The global healthcare landscape is increasingly reliant on immunoglobulins, a primary class of blood plasma derivatives used to treat a wide array of primary and secondary immunodeficiency disorders. As diagnostic capabilities improve worldwide, more patients are being identified with chronic conditions that require lifelong plasma-based therapies to prevent life-threatening infections. Beyond...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)